Monday news briefs – stories you might have missed

Respiri secures global sales and distribution agreement Asthma management system developer Respiri has signed an exclusive agreement with pharmaceutical firm Cipla to sell its Wheezo asthma management device. Cipla will initially market Wheezo in Australia and New Zealand, with further territories including the United States, Europe and India also on Cipla’s radar. Initial minimum sales…

Recce Pharmaceuticals tests Covid treatment

Recce Pharmaceuticals will trial its anti-infective agents RECCE 327 and RECCE 529 against SARS- CoV-2. The company has teamed with North Carolina’s Path BioAnalytics to trial its broad-spectrum synthetic antibiotics which the company is commercialising to defeat resistant superbugs, Researchers at PBA will evaluate the company’s drug candidates in an ‘ex vivo respiratory organoid model…

Elexon Electronics launches new advanced facility

Brisbane electronics manufacturer Elexon Electronics has opened a new state of the art ‘intelligent factory’ to help it enter new markets in defence and aerospace. State government politicians including manufacturing minister Glenn Butcher (pictured, at right) launched our the new facility along with CEO Frank Faller (left). The government supported the investment in automated surface-mount…